Home Daily Stock Opinions and Ratings Lemonade (LMND-N)

Trending stocks today

Royalty Pharma plc Comcast Corp Onity Group. Inc. Allstate CVS Health Corp Savaria Corp Jamieson Wellness Stella-Jones Inc. Tesla Inc CVS Health Corp Advanced Micro Devices Broadcom Mastercard Inc. Superior Plus Corp Omnicom Group GlaxoSmithKline PLC Leidos Holdings, Inc. Africa Oil Corp. International Petroleum Company Ecora Resources

Lemonade (LMND-N)

NEW AI Investor Insights
48 watching

NYSE:LMND

41.91
1.70 (4.23%) 1d
Dec 13, 2024, 9:00 pm
0
Investor Insights

This summary was created by AI, based on 1 opinions in the last 12 months.

The experts have varying opinions on the stock of Lemonade (LMND-N). Some believe that the numbers are okay, but they predict a giant short squeeze that will continue. They are considering taking profits, possibly by Friday. This indicates some level of uncertainty and caution surrounding the stock's performance in the near future.

Consensus
Mixed
Valuation
Fair Value
WAIT

Lemonade(LMND-N)

06/11/2024
Lemonade

Numbers were okay, but they're in a giant short squeeze that will continue. Will till Friday then maybe take some profits.

Financial Services
Jim Cramer - Mad Money
$29.290
Unknown
UnlockRating
HOLD

Lemonade(LMND-N)

31/10/2022
Lemonade
Artificial intelligence insurance company. Company shares have been hit very hard with tech selloff. Hoping to replace human element in insurance business. Burning through a lot of cash the next 2-4 years. Wants to see more cash flow before investing. Rising interest rates will negatively impact this business. Better options for investors.
Financial Services
Jamie Murray
$24.030
Unknown
UnlockRating
WEAK BUY

Lemonade(LMND-N)

13/10/2022
Lemonade
Likes it. Has it in some separately managed accounts willing to take on more risk. Only pure play insurance tech in the market. Produces its own software. Recently into auto insurance. Decent size. Good runway. (Analysts’ price target is $32.63)
Financial Services
Kim Bolton
$21.760
No
UnlockRating
WEAK BUY

Lemonade(LMND-N)

29/12/2021
Lemonade
Poster child for SaaS that's struggled this year. 12-month price target of $65.50. Long runway, but unprofitable. Rising interest rates contract the multiple. The only pure play insurance start up. Buy it here just under $40, with a close stop of $35.
Financial Services
Kim Bolton
$39.690
Unknown
UnlockRating
HOLD

Lemonade(LMND-N)

21/07/2021
Lemonade
Going into earnings, don't buy any more. That said, the stock has come down enough and won't anymore.
Financial Services
Jim Cramer - Mad Money
$92.200
Unknown
UnlockRating
COMMENT

Lemonade(LMND-N)

30/04/2021
Lemonade
Problem is, they offer a great product, but it's hard to determine the value of the stock. Also, this is heavily shorted so it's volatile (not a Reddit stock though). He likes it, but you'll have to wait for the value of the stock to catch up with the value proposition.
Financial Services
Jim Cramer - Mad Money
$90.400
Unknown
UnlockRating
DON'T BUY

Lemonade(LMND-N)

14/04/2021
Lemonade
2020 IPOs cost too much, and are worth buying now that they are out of style and cheaper. This insurance disruptor was worth buying below $50, which happened two months after its IPO. Then, it took off, but down 50% from its peak now. He loves this company, but they're losing tons of money and the stock trades at 50x sales (not earnings).
Financial Services
Jim Cramer - Mad Money
$88.600
Unknown
UnlockRating
COMMENT

Lemonade(LMND-N)

26/02/2021
Lemonade
An AI-powered insurance broker. 11% of shares were just shorted. They report Monday.
Financial Services
Jim Cramer - Mad Money
$125.790
Unknown
UnlockRating
PARTIAL SELL

Lemonade(LMND-N)

08/01/2021
Lemonade
Lemonade is an A.I. insurer and disruptor. He likes it. Lemonade shot up before Christmas, but plunged 14% Dec. 28 right before its next lock-up expired the following day. The company had traded only 11 million of a total 57 million as listed in their IPO. They unlocked 15 million in November, then 30 million more in late December. Heavy volatility followed to present. Then an investing article spurred a huge short squeeze. It now trades at absurd levels. Take profits here and don't tempt fate.
Financial Services
Jim Cramer - Mad Money
$160.740
Unknown
UnlockRating
COMMENT

Lemonade(LMND-N)

11/11/2020
Lemonade
It's a disruptive tech play on insurance, but also a puzzle. It stormed out of the gate as its IPO rose too high in late June. He waited for a pullback, that happened, and recently it's been rangebound. Despite a top- and bottom-line beat today, it sold off. He doesn't get it.
Financial Services
Jim Cramer - Mad Money
$57.900
Unknown
UnlockRating
BUY

Lemonade(LMND-N)

06/11/2020
Lemonade
They report next week and he expects good results when they report next. A new company that uses AI to shake up the insurance industry.
Financial Services
Jim Cramer - Mad Money
$61.370
Unknown
UnlockRating
BUY ON WEAKNESS

Lemonade(LMND-N)

19/10/2020
Lemonade
What he calls one of 15 Red Hot stocks: unstoppable growth stocks with a sky-high valuation (30-100x sales, not earnings) It's trying to revolutionize the insurance industry. He recommended a pullback to $60, which it is fallen to now. You can buy it now, or wait till it falls further, to $50.
Financial Services
Jim Cramer - Mad Money
$58.950
Unknown
UnlockRating
BUY

Lemonade(LMND-N)

09/09/2020
Lemonade
He likes it. It went public on July 2, and ran up in price quickly. It's a digitized insurance company, and why not in an age where so much is digitized?
Financial Services
Jim Cramer - Mad Money
$50.180
Unknown
UnlockRating
TOP PICK

Lemonade(LMND-N)

15/07/2020
Lemonade
His price target is $96. It was an IPO a couple of weeks ago that came out at $29. It is the only pure insurance start-up tech in the market presently. It does searches for insurance for home owners and renters. Put it on your radar -- only put down 20% of what you are willing to risk and be prepared to buy more at every $10 lower. It is a disruptor in the huge insurance industry. Yield 0%.
Financial Services
Kim Bolton
$74.170
Owned
UnlockRating
Showing 1 to 14 of 14 entries
  • «
  • ‹
  • 1
  • ›
  • »

Lemonade(LMND-N) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Lemonade is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Lemonade(LMND-N) Frequently Asked Questions

What is Lemonade stock symbol?

Lemonade is a American stock, trading under the symbol LMND-N on the New York Stock Exchange (LMND). It is usually referred to as NYSE:LMND or LMND-N

Is Lemonade a buy or a sell?

In the last year, there was no coverage of Lemonade published on Stockchase.

Is Lemonade a good investment or a top pick?

Lemonade was recommended as a Top Pick by on . Read the latest stock experts ratings for Lemonade.

Why is Lemonade stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Lemonade worth watching?

0 stock analysts on Stockchase covered Lemonade In the last year. It is a trending stock that is worth watching.

What is Lemonade stock price?

On 2024-12-13, Lemonade (LMND-N) stock closed at a price of $41.91.

Your Watchlist

Add stocks to watchlist to monitor them daily and get important alerts.

Get Access To Watchlist

Latest Buy Signals

GSY-Tgoeasy
goeasy
$161.86
0.20 (0.12%)
LHX-NL3Harris Technologies
L3Harris Technologies
$223.12
-1.23 (-0.55%)
MGA-TMega Uranium
Mega Uranium
$0.35
0.00 (0.00%)
DC.A-TDundee Corp. (A)
Dundee Corp. (A)
$1.59
0.01 (0.63%)
SGD-XSnowline Gold
Snowline Gold
$5.11
0.02 (0.39%)
Advertising

Today's Top Picks

ECOR-TEcora Resources
Ecora Resources
$1.31
0.13 (9.03%)
IPCO-TInternational Petroleum Company
International Petroleum Company
$16.05
0.21 (1.29%)
AOI-TAfrica Oil Corp.
Africa Oil Corp.
$1.94
0.04 (2.02%)
LDOS-NLeidos Holdings, Inc.
Leidos Holdings, Inc.
$153.16
0.18 (0.12%)
GSK-NGlaxoSmithKline PLC
GlaxoSmithKline PLC
$33.95
-0.22 (-0.65%)

Popular Articles

Questrade Review: Pros & Cons of Trading with Questrade Canada (2021) Steady Eddys: 3 Stable Stocks Between Safety and Risk: 3 Safe and Gambling Stocks 3 Oversold Stocks to Take Advantage of 5 ETFs for Index Investing

Latest Sell Signals

III-TImperial Metals Corp
Imperial Metals Corp
$1.93
-0.07 (-3.76%)
IMG-TIamgold Corp
Iamgold Corp
$7.60
-0.31 (-4.25%)
PPTA-QPerpetua Resources
Perpetua Resources
$11.91
0.10 (0.83%)
DG-NDollar General Corp.
Dollar General Corp.
$76.94
-1.48 (-1.96%)
VRT-NVertiv Holdings
Vertiv Holdings
$125.78
0.74 (0.58%)

Most Recent Experts

Rule

Rick Rule

Rule Investment Medial

Stockchase

Stockchase Insights

5i Research

Pyle

Andrew Pyle

The Pyle Group, Scotia Wealth Mgt.

Panic-Proof (Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Buzzing

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Advertising
Advertising
logoTop pickslogoStockslogoRecentlogoWatchlist
© Stockchase Inc.